Cryotherapy

Cryotherapy - Chillin' Like a Villain

• Definition: Controlled tissue destruction by applying extreme cold.
• Mechanism:
  • Freeze Phase: Rapid cooling → intracellular & extracellular ice crystals, ↑ solute concentration.
  • Thaw Phase: Slow thawing → recrystallization, osmotic shifts, cell membrane rupture.
  • Vascular stasis & inflammatory response → delayed tissue necrosis.
• Cryogens:
  • Liquid Nitrogen (LN₂): -196°C (most common).
  • Nitrous Oxide (N₂O): -89°C.
• Technique: "Rapid freeze, slow thaw" principle. Repeat freeze-thaw cycles (typically 2-3) enhance efficacy.

⭐ For benign lesions, target tissue temperature is -20°C to -30°C; for malignant lesions, -40°C to -60°C is required.

Cryogens & Delivery - Ice Ice Arsenal

• Cryogens (Boiling Point):
  • Liquid Nitrogen (LN2): -196°C (Gold standard, most effective)
  • Nitrous Oxide (N2O): -89°C (Used in cryo-pens)
  • Carbon Dioxide (CO2) Snow: -78.5°C (Older method)
  • Dimethyl Ether/Propane (DMEP): -57°C (OTC wart removers)
• Delivery Systems:
  • Sprays: Open (direct) or confined (cones); versatile.
  • Contact Probes (Cryoprobes): Metal probes, good for defined areas.
  • Cotton-tipped Applicators: Dipstick method; for small, superficial lesions.

⭐ LN2 is the most common cryogen, achieving the lowest temperature (-196°C) for maximal cell destruction.

Indications - Freeze These Foes

Error: Failed to generate content for this concept group.

Technique - The Freeze Protocol

• Preparation: Debulk (e.g., curettage for warts/SKs); cleanse site; LA (optional).
• Application Methods:
  • Open Spray: LN2 via nozzle (1-2 cm distance from skin).
  • Contact Probe: Cooled metal probe directly on lesion.
• Freeze-Thaw Cycles (Standard):
  • Freeze Time: Benign lesions (5-30s); Malignant lesions (30-60s+, often longer).
  • Thaw Time: Crucial; allow complete thaw (typically 2-3x freeze time).
  • Cycles: 1-3 cycles common.
• Endpoint: Achieve adequate frozen tissue halo/margin.
  • Benign: 1-2 mm.
  • Malignant: 3-5 mm.

⭐ Rapid freeze (forms intracellular ice) & slow thaw (allows crystal growth) maximizes cryonecrosis.

Complications & Aftercare - Post-Chill Fallout

• Immediate: Pain, edema, bullae (serous/hemorrhagic).
• Delayed:
  • Pigmentary changes: Hypo- (common) or hyperpigmentation. ⚠️ Higher risk in dark skin.
  • Scarring (rare, hypertrophic/keloid).
  • Nerve damage (transient paresthesia; esp. digits).
  • Alopecia (scalp lesions); Milia.
  • Infection (rare).
• Aftercare:
  • Gentle cleansing; avoid picking.
  • Blisters: Leave intact; aspirate if large/painful.
  • Analgesia (paracetamol/NSAIDs).
  • Sun protection (SPF >30) crucial.
  • Topical antibiotic if signs of infection.

⭐ Hypopigmentation is the most common long-term complication, especially in darker skin types. oka

High‑Yield Points - ⚡ Biggest Takeaways

• Liquid nitrogen (-196°C) is the primary cryogen, causing cell death by ice crystal formation.
• Commonly treats benign lesions like warts, molluscum contagiosum, seborrheic keratosis, and actinic keratosis.
• Can be used for superficial basal cell carcinoma (BCC).
• Application methods include spray, contact probe, and cotton-tipped applicator.
• Two freeze-thaw cycles enhance efficacy, particularly for malignant or resistant lesions.
• Common side effects: pain, blistering, and hypopigmentation (most persistent).
• Avoid in melanoma, sclerosing BCC, and cold-sensitive conditions (e.g., cryoglobulinemia).